To further characterize the underlying molecular mechanisms by which GHET1 modulated the growth of ovarian cancer cells, we screened the potential binding partners of GHET1 with the RNA pull-down and mass spectrometry analysis. The gene discussed is GHET1; the disease is ovarian cancer.